Lepu Biopharma Co., Ltd. (2157.HK)

HKD 3.31

(0.91%)

Annual Income Statements

(In CNY)
Breakdown 2023 2022 2021 2020 2019
Revenue 225.35 Million 15.57 Million - - -
Cost of Revenue 28.27 Million 2 Million - - -
Gross Profit 197.07 Million 13.56 Million - - -
Operating Expenses 192.27 Million 655.6 Million 944.08 Million 449.32 Million 419.1 Million
Selling, General and Administrative Expenses 129.95 Million 140.57 Million 156.23 Million 27.28 Million 16.97 Million
Research and Development Expenses 458.07 Million 524.28 Million 791.21 Million 354.42 Million 229.19 Million
Other Expenses -395.74 Million 1.11 Million 140 Thousand 2.08 Million 1.02 Million
Cost and Expenses 220.55 Million 657.6 Million 944.08 Million 449.32 Million 419.1 Million
Operating Income 4.79 Million -704.48 Million -1 Billion -520.35 Million -454.65 Million
Interest Expense 14.67 Million 7.46 Million 2.69 Million 85.2 Million 52.32 Million
Income Tax Expense - 65.68 Million 31.28 Million 33.62 Million -40.39 Million
Earnings before Tax -30.3 Million -699.44 Million -1.02 Billion -613.44 Million -515.49 Million
Net Income -22.09 Million -689.05 Million -1.01 Billion -581.84 Million -447.03 Million
Earnings Per Share Basic -0.01 -0.42 -0.61 -0.35 -0.27
Earnings Per Share Diluted -0.01 -0.42 -0.61 -0.35 -0.27
Weighted Average Shares Outstanding 1.65 Billion 1.64 Billion 1.65 Billion 1.65 Billion 1.65 Billion
Weighted Average Shares Outstanding (Diluted) 1.65 Billion 1.64 Billion 1.65 Billion 1.65 Billion 1.65 Billion
Gross Margin 0.87 0.87 - - -
EBIT Margin 0.39 -34.23 - - -
Profit Margin -0.10 -44.25 - - -
EBITDA 86.94 Million -596.52 Million -865.23 Million -371.01 Million -377.32 Million
Earnings Before Tax Margin 0.02 -45.24 - - -

Income Statement Charts